1345442-91-2Relevant academic research and scientific papers
PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS
-
Paragraph 0797; 0798, (2017/10/13)
This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.
NEW CHEMICAL COMPOUNDS
-
Page/Page column 24; 26, (2012/04/23)
The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, Qa, Qb, QH, L and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
HETEROCYCLIC CARBOXYLIC ACID AMIDES AS PDK1 INIHIBITORS
-
Page/Page column 54; 56, (2011/11/06)
The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, Qa, Qb, QH, L and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
1H - IMIDAZO [4, 5 - C] QUINOLINES
-
Page/Page column 46; 48, (2011/12/04)
The present invention encompasses compounds of general formula (1), wherein the groups R1 to R7, Qa, Qb, L, n and m are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations containing such compounds and their use as medicaments.
